Checchi Capital Advisers, LLC Biogen Inc. Transaction History

Checchi Capital Advisers, LLC

$1.78 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $220,561 - $283,453	-985 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $3,678 - $4,797	-13 Reduced 1.3%	985 $279,000
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $25,123 - $40,226	-97 Reduced 8.86%	998 $346,000
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $8,746 - $10,246	-36 Reduced 3.18%	1,095 $306,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $104,663 - $157,544	-443 Reduced 28.14%	1,131 $277,000
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $24,094 - $27,819	-91 Reduced 5.47%	1,574 $447,000
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $21,210 - $28,089	82 Added 5.18%	1,665 $445,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $5,108 - $6,479	-19 Reduced 1.19%	1,583 $501,000
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $6,161 - $8,513	-28 Reduced 1.72%	1,602 $475,000
Q3 2019 Nov 06, 2019	SELL	$217.44 - $243.88 $5,653 - $6,340	-26 Reduced 1.57%	1,630 $379,000
Q2 2019 Aug 06, 2019	BUY	$219.29 - $241.72 $9,868 - $10,877	45 Added 2.79%	1,656 $387,000
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $19,287 - $30,167	-89 Reduced 5.24%	1,611 $381,000
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $90,791 - $114,996	-326 Reduced 16.09%	1,700 $512,000
Q3 2018 Oct 29, 2018	BUY	$293.51 - $383.83 $9,685 - $12,666	33 Added 1.66%	2,026 $716,000
Q2 2018 Aug 06, 2018	BUY	$257.52 - $306.91 $8,240 - $9,821	32 Added 1.63%	1,993 $578,000
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $13,786 - $19,499	53 Added 2.78%	1,961 $537,000
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $99,675 - $111,643	324 Added 20.45%	1,908 $608,000
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $445,341 - $522,228	1,584	1,584 $496,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.

Account